Table 2.
Thromboelastometric results of the different tests with edoxaban and apixaban. Data are presented as median and (Q1/Q3)
| Apixaban | Edoxaban | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 ng/ml | 31.25 ng/ml | 62.5 ng/ml | 125 ng/ml | 250 ng/ml | 500 ng/ml | 0 ng/ml | 31.25 ng/ml | 62.5 ng/ml | 125 ng/ml | 250 ng/ml | 500 ng/ml | |
| CT NATEM | 802 (678/875) | 799 (701/882) | 802 (761/955) | 824 (694/925) | 1006 (824/1110) | 1017 (905/1085) | 756 (574/875) | 802 (586/886) | 795 (719/969) | 894 (737/1199) | 1212 (995/1338) | 1231 (1108/1405) |
| CT EXTEM | 56 (52/63) | 61 (59/67) | 66 (61/72) | 72 (69/75) | 88 (81/97) | 115 (98/129) | 57 (56/62) | 79 (76/80) | 86 (84/90) | 108 (102/120) | 175 (148/202) | 255 (215/284) |
| CT FIBTEM | 57 (54/64) | 59 (58/63) | 64 (59/67) | 69 (66/76) | 83 (80/93) | 114 (107/128) | 54 (53/56) | 73 (71/75) | 87 (81/89) | 106 (93/115) | 176 (149/202) | 245 (208/296) |
| CT HEPTEM | 176 (173/210) | 194 (184/202) | 196 (192/201) | 199 (186/214) | 217 (198/224) | 238 (219/246) | 189 (182/196) | 211 (200/216) | 222 (195/230) | 236 (228/247) | 268 (258/280) | 346 (326/359) |
| CT TFTEM | 152 (117/177) | 185 (157/209) | 228 (173/286) | 281 (256/303) | 338 (324/386) | 489 (419/522) | 118 (106/136) | 261 (215/293) | 285 (274/350) | 362 (334/413) | 478 (425/509) | 621 (588/680) |
| CT ECATEM | 99 (92/108) | 93 (88/109) | 96 (89/104) | 97 (87/100) | 96 (89/104) | 90 (86/95) | 97 (92/101) | 92 (84/97) | 97 (89/101) | 95 (87/97) | 98 (94/103) | 96 (86/102) |
CT Clotting time